BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21116130)

  • 1. N-terminal RASSF family: RASSF7-RASSF10.
    Underhill-Day N; Hill V; Latif F
    Epigenetics; 2011 Mar; 6(3):284-92. PubMed ID: 21116130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.
    Djos A; Martinsson T; Kogner P; Carén H
    Mol Cancer; 2012 Jun; 11():40. PubMed ID: 22695170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RASSF proteins in cancer; from epigenetic silencing to functional characterization.
    Richter AM; Pfeifer GP; Dammann RH
    Biochim Biophys Acta; 2009 Dec; 1796(2):114-28. PubMed ID: 19344752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Shen S; Guo X; Kuang G; Yang Z
    Mol Carcinog; 2016 Nov; 55(11):1655-1666. PubMed ID: 26456015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.
    Hesson LB; Dunwell TL; Cooper WN; Catchpoole D; Brini AT; Chiaramonte R; Griffiths M; Chalmers AD; Maher ER; Latif F
    Mol Cancer; 2009 Jul; 8():42. PubMed ID: 19570220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
    Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer and RASSF family--a special emphasis on RASSF1A.
    Fernandes MS; Carneiro F; Oliveira C; Seruca R
    Int J Cancer; 2013 Jan; 132(2):251-8. PubMed ID: 22733432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation status of Ras-association domain family members in pheochromocytoma.
    Richter AM; Zimmermann T; Haag T; Walesch SK; Dammann RH
    Front Endocrinol (Lausanne); 2015; 6():21. PubMed ID: 25750636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASSF6 is a novel member of the RASSF family of tumor suppressors.
    Allen NP; Donninger H; Vos MD; Eckfeld K; Hesson L; Gordon L; Birrer MJ; Latif F; Clark GJ
    Oncogene; 2007 Sep; 26(42):6203-11. PubMed ID: 17404571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia.
    Shinawi T; Hill V; Dagklis A; Baliakas P; Stamatopoulos K; Agathanggelou A; Stankovic T; Maher ER; Ghia P; Latif F
    Epigenetics; 2012 Mar; 7(3):211-5. PubMed ID: 22430796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
    Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
    Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
    Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
    Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
    Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
    Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.
    Li Z; Chang X; Dai D; Deng P; Sun Q
    Oncol Rep; 2014 Apr; 31(4):1661-8. PubMed ID: 24573726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF6; the Putative Tumor Suppressor of the RASSF Family.
    Iwasa H; Jiang X; Hata Y
    Cancers (Basel); 2015 Dec; 7(4):2415-26. PubMed ID: 26690221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
    Gharanei S; Brini AT; Vaiyapuri S; Alholle A; Dallol A; Arrigoni E; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
    Epigenetics; 2013 Sep; 8(9):893-8. PubMed ID: 23887284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ras-association domain family (RASSF) members and their role in human tumourigenesis.
    van der Weyden L; Adams DJ
    Biochim Biophys Acta; 2007 Sep; 1776(1):58-85. PubMed ID: 17692468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic inactivation of RASSF10 in thyroid cancer.
    Schagdarsurengin U; Richter AM; Wöhler C; Dammann RH
    Epigenetics; 2009 Nov; 4(8):571-6. PubMed ID: 19934646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.
    Eckfeld K; Hesson L; Vos MD; Bieche I; Latif F; Clark GJ
    Cancer Res; 2004 Dec; 64(23):8688-93. PubMed ID: 15574778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
    Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
    Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.